10/1/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $63.00 ➝ $63.00 | |
9/9/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight | | |
8/12/2024 | Leerink Partnrs | Upgrade | Strong-Buy | | |
8/12/2024 | Leerink Partners | Initiated Coverage | Outperform | $70.00 | |
8/8/2024 | HC Wainwright | Boost Target | Buy ➝ Buy | $60.00 ➝ $63.00 | |
8/6/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight | | |
7/2/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $60.00 ➝ $60.00 | |
5/23/2024 | William Blair | Reiterated Rating | Outperform | | |
5/10/2024 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $87.00 ➝ $86.00 | |
3/20/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $60.00 | |
3/8/2024 | William Blair | Reiterated Rating | Outperform | | |
2/8/2024 | Citigroup | Boost Target | Buy ➝ Buy | $40.00 ➝ $48.00 | |
12/13/2023 | Canaccord Genuity Group | Initiated Coverage | Buy | | |
12/13/2023 | Canaccord Genuity Group | Initiated Coverage | Buy | $90.00 | |
11/28/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 | |
11/15/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 | |
11/15/2023 | William Blair | Reiterated Rating | Outperform | | |
11/6/2023 | William Blair | Reiterated Rating | Outperform | | |
9/27/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 | |
9/20/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 | |
9/5/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 | |
8/22/2023 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $54.00 | |
8/15/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 | |
8/8/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 | |
7/24/2023 | William Blair | Initiated Coverage | Outperform | $71.00 | |
7/17/2023 | Wells Fargo & Company | Boost Target | | $35.00 ➝ $45.00 | |
7/14/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $51.00 | |
7/14/2023 | Guggenheim | Reiterated Rating | Buy | | |
7/14/2023 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $54.00 | |
5/15/2023 | Cantor Fitzgerald | Reiterated Rating | Overweight | | |
5/11/2023 | HC Wainwright | Upgrade | Neutral ➝ Buy | $19.00 ➝ $51.00 | |
3/29/2023 | HC Wainwright | Reiterated Rating | Neutral | $19.00 | |
3/29/2023 | Guggenheim | Reiterated Rating | Buy | $36.00 | |
11/14/2022 | Wells Fargo & Company | Initiated Coverage | Overweight | $35.00 | |
11/10/2022 | The Goldman Sachs Group | Boost Target | Sell | $8.00 ➝ $14.00 | |
11/10/2022 | Robert W. Baird | Downgrade | Neutral ➝ Underperform | $18.00 | |
11/3/2022 | Citigroup | Upgrade | Neutral ➝ Buy | $22.00 ➝ $35.00 | |
11/2/2022 | Barclays | Upgrade | Underweight ➝ Equal Weight | $16.00 ➝ $25.00 | |
11/2/2022 | Cantor Fitzgerald | Boost Target | Overweight | $39.00 ➝ $44.00 | |
8/10/2022 | Brookline Capital Management | Reiterated Rating | Buy | | |
8/10/2022 | Wells Fargo & Company | Lower Target | Overweight | $105.00 ➝ $98.00 | |
8/10/2022 | Barclays | Lower Target | Underweight | $17.00 ➝ $16.00 | |
8/10/2022 | Raymond James | Downgrade | Market Perform ➝ Underperform | | |
5/24/2022 | The Goldman Sachs Group | Lower Target | Sell | $14.00 ➝ $8.00 | |
5/11/2022 | Guggenheim | Lower Target | | $83.00 ➝ $36.00 | |
5/11/2022 | Robert W. Baird | Upgrade | Underperform ➝ Neutral | $21.00 ➝ $18.00 | |
5/10/2022 | Barclays | Lower Target | | $21.00 ➝ $17.00 | |
5/10/2022 | HC Wainwright | Lower Target | | $25.00 ➝ $19.00 | |
5/9/2022 | Cantor Fitzgerald | Reiterated Rating | Overweight | | |
4/21/2022 | Citigroup | Downgrade | Buy ➝ Neutral | $86.00 ➝ $29.00 | |
3/25/2022 | Wells Fargo & Company | Lower Target | Overweight | $107.00 ➝ $105.00 | |
3/15/2022 | Citigroup | Lower Target | Buy | $114.00 ➝ $86.00 | |
3/1/2022 | HC Wainwright | Lower Target | | $47.00 ➝ $25.00 | |
3/1/2022 | Wells Fargo & Company | Lower Target | Overweight | $118.00 ➝ $107.00 | |
3/1/2022 | Cantor Fitzgerald | Lower Target | | $93.00 ➝ $86.00 | |
3/1/2022 | Barclays | Lower Target | | $31.00 ➝ $21.00 | |
1/31/2022 | Raymond James | Upgrade | Underperform ➝ Market Perform | | |
1/26/2022 | HC Wainwright | Lower Target | | $47.00 ➝ $33.00 | |
11/16/2021 | Cantor Fitzgerald | Boost Target | Overweight | $85.00 ➝ $93.00 | |
11/9/2021 | Barclays | Lower Target | Positive ➝ Underweight | $46.00 ➝ $31.00 | |
8/25/2021 | Citigroup | Lower Target | Buy | $118.00 ➝ $114.00 | |
8/12/2021 | Raymond James | Downgrade | Market Perform ➝ Underperform | | |
8/10/2021 | The Goldman Sachs Group | Downgrade | Neutral ➝ Sell | $29.00 | |
8/10/2021 | Cantor Fitzgerald | Boost Target | Overweight | $71.00 ➝ $85.00 | |
8/10/2021 | Robert W. Baird | Downgrade | Neutral ➝ Underperform | $31.00 | |
7/2/2021 | Cantor Fitzgerald | Initiated Coverage | Overweight | $71.00 | |
6/24/2021 | The Goldman Sachs Group | Initiated Coverage | Neutral | $29.00 ➝ $34.00 | |
6/21/2021 | Barclays | Downgrade | Equal Weight ➝ Underweight | $33.00 ➝ $25.00 | |
5/12/2021 | B. Riley | Reiterated Rating | Sell | $35.00 ➝ $23.00 | |
5/11/2021 | Barclays | Lower Target | Equal Weight | $46.00 ➝ $33.00 | |
3/8/2021 | B. Riley | Lower Target | Positive ➝ Sell | $45.00 ➝ $35.00 | |
3/2/2021 | Roth Capital | Lower Target | Sell | $77.00 ➝ $45.00 | |
2/17/2021 | B. Riley | Downgrade | Neutral ➝ Sell | | |
1/15/2021 | B. Riley | Downgrade | Buy ➝ Neutral | $138.00 ➝ $77.00 | |
1/7/2021 | Wells Fargo & Company | Initiated Coverage | Overweight | $118.00 | |
12/29/2020 | HC Wainwright | Downgrade | Buy ➝ Neutral | $84.00 ➝ $50.00 | |
12/29/2020 | Robert W. Baird | Downgrade | Outperform ➝ Neutral | $79.00 ➝ $69.00 | |
12/29/2020 | Barclays | Downgrade | Overweight ➝ Equal Weight | $68.00 ➝ $46.00 | |
12/29/2020 | Raymond James | Downgrade | Outperform ➝ Market Perform | $46.00 | |
12/23/2020 | Roth Capital | Downgrade | Buy ➝ Sell | $77.00 | |
12/14/2020 | Smith Barney Citigroup | Boost Target | | $62.00 ➝ $133.00 | |
12/7/2020 | B. Riley | Boost Target | Buy | $64.00 ➝ $111.00 | |
11/11/2020 | B. Riley | Lower Target | Buy | $82.00 ➝ $64.00 | |
11/10/2020 | Raymond James | Lower Target | Outperform | $79.00 ➝ $73.00 | |
10/26/2020 | Barclays | Initiated Coverage | Overweight | $72.00 | |
10/6/2020 | Citigroup | Initiated Coverage | Buy ➝ Buy | $65.00 | |
8/25/2020 | Piper Sandler | Initiated Coverage | Overweight | $77.00 | |
8/12/2020 | B. Riley | Boost Target | | $70.00 ➝ $82.00 | |
8/11/2020 | Brookline Capital Management | Reiterated Rating | Buy | | |
8/11/2020 | Raymond James | Boost Target | Outperform | $72.00 ➝ $79.00 | |
8/11/2020 | HC Wainwright | Reiterated Rating | Buy | $78.00 | |
7/30/2020 | Roth Capital | Initiated Coverage | Buy | $77.00 | |
7/24/2020 | Raymond James | Reiterated Rating | Buy | | |
7/24/2020 | HC Wainwright | Boost Target | Buy | $62.00 ➝ $78.00 | |
7/16/2020 | Raymond James | Initiated Coverage | Outperform | $72.00 | |
7/12/2020 | B. Riley | Initiated Coverage | Buy | $70.00 | |
6/9/2020 | WBB Securities | Downgrade | Buy ➝ Hold | $31.00 | |
5/4/2020 | HC Wainwright | Reiterated Rating | Buy | $62.00 | |
4/28/2020 | HC Wainwright | Boost Target | Buy | $26.00 ➝ $62.00 | |
4/14/2020 | HC Wainwright | Boost Target | Buy | $24.00 ➝ $26.00 | |
3/18/2020 | Robert W. Baird | Reiterated Rating | Buy | $26.00 | |
3/12/2020 | HC Wainwright | Boost Target | Buy | $18.00 ➝ $24.00 | |
3/5/2020 | LADENBURG THALM/SH SH | Boost Target | | $22.00 ➝ $28.00 | |
3/4/2020 | HC Wainwright | Reiterated Rating | Buy | $18.00 | |
3/4/2020 | Roth Capital | Boost Target | Buy | $14.00 ➝ $24.00 | |
2/10/2020 | Robert W. Baird | Initiated Coverage | Outperform | $24.00 | |
2/6/2020 | Guggenheim | Initiated Coverage | Buy | $19.00 | |
1/9/2020 | HC Wainwright | Reiterated Rating | Buy | $18.00 | |